Real-World Outcomes and Risk Factors in Multiple Myeloma Pts Receiving Cilta-Cel Including Functional High-Risk Status

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Kenneth J C Lim, Ricardo Daniel Parrondo, Saurabh Chhabra, Katharine E. Dooley, Andre De Menezes Silva Corraes, Morie Abraham Gertz, L. Y. hwa, H. J. B. Stephens, Prashant Kapoor, Taxiarchis Kourelis, Rahma M. Warsame, Joselle Cook
+12 more Moritz Binder, Peter Leif Bergsagel, Melinda Tan, Udit Yadav, Julia Erin Wiedmeier-Nutor, Susan Geyer, Nadine H. Abdallah, Sikander Ailawadhi, Rafael Fonseca, Shaji Kumar, Yi Lin, Saurabh Zanwar
DOI: 10.1016/j.jtct.2025.12.617
Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments CAR-T cell therapy research Multiple Sclerosis Research Studies

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S429–S430
Publication date
1 February 2026
Language
EN